Table 1.
Demographic, baseline physical exam and previous SARS-CoV-2 infection in the study groups.
| Variables | Total patients (n = 173) |
Placebo (n = 86) |
Domperidone (n = 87) |
p value | |||
|---|---|---|---|---|---|---|---|
| N (%) | Mean (SD) | N (%) | Mean (SD) | N (%) | Mean (SD) | ||
| Gender | |||||||
| Male | 64 (37) | 33 (38.4) | 31 (35.6) | 0.709 | |||
| Female | 109 (63) | 53 (61.6) | 56 (64.4) | ||||
| Age (years) | 47.8 (1.2) | 47.7 (1.7) | 47.8 (1.6) | ||||
| Race | |||||||
| Caucasian | 154 (89) | 74 (86) | 80 (92) | 0.431 | |||
| Black | 1 (0.6) | 1 (1.2) | 0 | ||||
| Hispanic | 17 (9.8) | 10 (11.6) | 7 (8) | ||||
| Asiatic | 1 (0.6) | 1 (1.2) | 0 | ||||
| Body mass index (kg/m2) | 26 (0.4) | 26.6 (0.6) | 25.5 (0.5) | 0.323 | |||
| Systolic BP (mmHg) | 124.6 (1) | 124.4 (1.5) | 124.7 (1.3) | 0.890 | |||
| Diastolic BP (mmHg) | 76.7 (0.8) | 76.4 (1.1) | 77 (1) | 0.719 | |||
| Respiratory rate (breaths/min) | 15.9 (0.4) | 15.6 (0.4) | 16.3 (0.8) | 0.389 | |||
| Oxygen saturation (%) | 97.2 (0.1) | 97.1 (0.1) | 97.3 (0.1) | 0.318 | |||
| Heart rate (beats/min) | 81.8 (1) | 83.1 (1.5) | 80.6 (1.3) | 0.306 | |||
| Axillary temperature (°x) | 36.4 (0.1) | 36.5 (0.1) | 36.4 (0.1) | 0.788 | |||
| Previous COVID-19 infection | |||||||
| No | 146 (84.4) | 73 (84.9) | 73 (83.9) | 0.860 | |||
| Yes | 27 (15.6) | 13 (15.1) | 14 (16.1) | ||||
| Severity of previous COVID-19 infection | |||||||
| Asymptomatic | 1 (3.7) | 1 (7.7) | 0 | ||||
| Mild | 17 (63) | 10 (76.9) | 7 (50) | ||||
| Moderate | 8 (29.6) | 2 (15.4) | 6 (42.9) | ||||
| Severe | 1 (3.7) | 0 | 1 (7.1) | ||||
| Time from previous SARS-CoV-2 infection (months) | 14.2 (1.7) | 12.6 (2.6) | 15.8 (2.1) | 0.342 | |||
SD: standard deviation.